Goel Shiba, Bhardwaj Neerja, Jain Kajal
Department of Anaesthesia and Intensive Care, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Paediatr Anaesth. 2008 Jul;18(7):628-34. doi: 10.1111/j.1460-9592.2008.02563.x. Epub 2008 May 8.
Use of midazolam and ketamine lowers the induction dose of propofol (co-induction) producing hemodynamic stability.
Large doses of propofol needed for induction and laryngeal mask (LM) insertion in children may be associated with hemodynamic and respiratory effects. Co-induction has the advantage of reducing dose and therefore maintaining hemodynamic stability.
To examine the effect of co-induction on hemodynamics, LM insertion and recovery in children.
METHODS/MATERIALS: A prospective, randomized, double-blind, controlled study was conducted in 60 ASA I/II children, age 1-8 years. Normal saline, ketamine 0.5 mg.kg(-1), midazolam 0.05 mg.kg(-1) were administered in groups P (propofol), PK (propofol-ketamine) and PM (propofol-midazolam), respectively, 2 min prior to the administration of the induction dose of propofol. Propofol 3.5 mg.kg(-1) (group P) or 2.5 mg.kg(-1) (groups PK and PM) was used for induction, LM inserted 30 s later and insertion conditions assessed. Heart rate and blood pressure were recorded immediately after propofol bolus, then every min till 2 min after LMA insertion. Recovery was assessed using Steward's Score.
In group P, systolic blood pressure (SBP) showed a significantly greater decrease compared to group PK and group PM (P < 0.005). Only 5% of patients in groups PK and PM showed >20% fall in SBP compared to 89% in group P (P < 0.005). More children in groups PK and PM had acceptable conditions for LM insertion compared to group P (P < 0.05). The time to achieve Steward Score of 6 was longer in groups PK and PM compared to group P (P < 0.005).
In children, the combination of propofol with ketamine or midazolam produces stable hemodynamics and improved LM insertion conditions but is associated with delayed recovery.
使用咪达唑仑和氯胺酮可降低丙泊酚诱导剂量(联合诱导),并产生血流动力学稳定性。
儿童诱导和插入喉罩(LM)所需的大剂量丙泊酚可能会产生血流动力学和呼吸方面的影响。联合诱导具有减少剂量从而维持血流动力学稳定性的优势。
研究联合诱导对儿童血流动力学、LM插入及苏醒的影响。
方法/材料:对60例年龄1 - 8岁的美国麻醉医师协会(ASA)I/II级儿童进行了一项前瞻性、随机、双盲、对照研究。在给予丙泊酚诱导剂量前2分钟,分别向P组(丙泊酚组)、PK组(丙泊酚 - 氯胺酮组)和PM组(丙泊酚 - 咪达唑仑组)给予生理盐水、0.5mg·kg⁻¹氯胺酮、0.05mg·kg⁻¹咪达唑仑。诱导时P组使用3.5mg·kg⁻¹丙泊酚,PK组和PM组使用2.5mg·kg⁻¹丙泊酚,30秒后插入LM并评估插入条件。在丙泊酚推注后立即记录心率和血压,然后每隔1分钟记录直至LMA插入后2分钟。使用Steward评分评估苏醒情况。
与PK组和PM组相比,P组收缩压(SBP)下降幅度显著更大(P < 0.005)。PK组和PM组仅5%的患者SBP下降>20%,而P组为89%(P < 0.005)。与P组相比,PK组和PM组更多儿童的LM插入条件可接受(P < 0.05)。与P组相比,PK组和PM组达到Steward评分为6的时间更长(P < 0.005)。
在儿童中,丙泊酚与氯胺酮或咪达唑仑联合使用可产生稳定的血流动力学并改善LM插入条件,但与苏醒延迟有关。